1,3-dipropyl-8-(4-sulfophenyl)xanthine has been researched along with oxidopamine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Osswald, W | 1 |
| Crone, C; Fuglsang, A; Therkildsen, P | 1 |
| Albino-Teixeira, A; Morato, M; Sousa, T | 1 |
3 other study(ies) available for 1,3-dipropyl-8-(4-sulfophenyl)xanthine and oxidopamine
| Article | Year |
|---|---|
Mediation by adenosine of the trophic effects exerted by the sympathetic innervation of blood vessels.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Dogs; Inosine; Muscle Denervation; Muscle, Smooth, Vascular; Norepinephrine; Oxidopamine; Purinergic Antagonists; Receptors, Purinergic; Reference Values; Saphenous Vein; Sympathectomy; Sympathectomy, Chemical; Vasodilator Agents; Xanthines | 1991 |
Presynaptic modulation of sympathetic nerve transmission--an element in vasomotor control.
Topics: Adenosine; Adrenergic alpha-Antagonists; Animals; Hydroxydopamines; Muscles; Oxidopamine; Phentolamine; Phenylisopropyladenosine; Rana temporaria; Receptors, Purinergic; Sympathetic Nervous System; Synaptic Transmission; Tetrodotoxin; Theophylline; Vasomotor System; Video Recording; Xanthines | 1989 |
Angiotensin converting enzyme inhibition prevents trophic and hypertensive effects of an antagonist of adenosine receptors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arteries; Blood Pressure; Body Weight; Captopril; Cell Size; Heart; Hypertension; Hypertrophy; Male; Mesenteric Arteries; Muscle, Smooth, Vascular; Organ Size; Oxidopamine; Peptidyl-Dipeptidase A; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Sympathectomy; Sympatholytics; Tail; Xanthines | 2002 |